Drug Type Microbiota |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication |
Originator Organization Alveolus Bio, Inc.Startup |
Active Organization Alveolus Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bronchopulmonary Dysplasia | Preclinical | US | Alveolus Bio, Inc.Startup | 21 Jul 2023 |
Pulmonary Disease, Chronic Obstructive | Preclinical | US | Alveolus Bio, Inc.Startup | 21 Jul 2023 |
Pulmonary Fibrosis | Preclinical | US | Alveolus Bio, Inc.Startup | 21 Jul 2023 |
Virus Diseases | Preclinical | US | Alveolus Bio, Inc.Startup | 21 Jul 2023 |